EGFR and non-small cell lung carcinoma: Analysis of SCLC tumors utilizing patient tumors and mouse models suggest that the SCLC phenotype can be developed due to transformation or trans-differentiation of NSCLC adenocarcinoma, as a result of RB1 inactivation and/or loss of EGFR expression, as recently reviewed extensively (49, 50).